vs
Side-by-side financial comparison of Avidbank Holdings, Inc. (AVBH) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $28.0M, roughly 1.7× Avidbank Holdings, Inc.). Avidbank Holdings, Inc. runs the higher net margin — 32.3% vs -4.8%, a 37.0% gap on every dollar of revenue.
Avidbank Holdings, Inc. is a U.S.-based financial holding company operating through its subsidiary AvidBank. It offers commercial banking products and services primarily to small and medium-sized enterprises, business owners, and high-net-worth individuals across California, including commercial loans, deposit accounts, cash management, and customized financing solutions for sectors like manufacturing, technology, real estate and professional services.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
AVBH vs IRWD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $28.0M | $47.7M |
| Net Profit | $9.0M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | — | 14.3% |
| Net Margin | 32.3% | -4.8% |
| Revenue YoY | — | -47.3% |
| Net Profit YoY | 65.9% | -200.9% |
| EPS (diluted) | $0.84 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $28.0M | — | ||
| Q4 25 | $26.8M | $47.7M | ||
| Q3 25 | $48.0K | $122.1M | ||
| Q2 25 | $21.8M | $85.2M | ||
| Q1 25 | — | $41.1M | ||
| Q4 24 | — | $90.5M | ||
| Q3 24 | — | $91.6M | ||
| Q2 24 | — | $94.4M |
| Q1 26 | $9.0M | — | ||
| Q4 25 | $6.9M | $-2.3M | ||
| Q3 25 | $-37.7M | $40.1M | ||
| Q2 25 | $5.8M | $23.6M | ||
| Q1 25 | — | $-37.4M | ||
| Q4 24 | — | $2.3M | ||
| Q3 24 | — | $3.6M | ||
| Q2 24 | — | $-860.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | 14.3% | ||
| Q3 25 | -110491.7% | 61.8% | ||
| Q2 25 | 38.0% | 53.2% | ||
| Q1 25 | — | -70.7% | ||
| Q4 24 | — | 34.8% | ||
| Q3 24 | — | 28.0% | ||
| Q2 24 | — | 26.5% |
| Q1 26 | 32.3% | — | ||
| Q4 25 | 25.9% | -4.8% | ||
| Q3 25 | -78614.6% | 32.8% | ||
| Q2 25 | 26.6% | 27.7% | ||
| Q1 25 | — | -90.9% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | -0.9% |
| Q1 26 | $0.84 | — | ||
| Q4 25 | $0.65 | $0.01 | ||
| Q3 25 | $-4.12 | $0.23 | ||
| Q2 25 | $0.75 | $0.14 | ||
| Q1 25 | — | $-0.23 | ||
| Q4 24 | — | $0.03 | ||
| Q3 24 | — | $0.02 | ||
| Q2 24 | — | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $215.5M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $287.2M | $-261.8M |
| Total Assets | $2.5B | $396.9M |
| Debt / EquityLower = less leverage | 0.19× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $215.5M | ||
| Q3 25 | — | $140.4M | ||
| Q2 25 | — | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | — | $88.6M | ||
| Q3 24 | — | $88.2M | ||
| Q2 24 | — | $105.5M |
| Q1 26 | $55.0M | — | ||
| Q4 25 | $60.0M | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M |
| Q1 26 | $287.2M | — | ||
| Q4 25 | $278.4M | $-261.8M | ||
| Q3 25 | $273.1M | $-264.2M | ||
| Q2 25 | $204.4M | $-308.2M | ||
| Q1 25 | — | $-334.1M | ||
| Q4 24 | — | $-301.3M | ||
| Q3 24 | — | $-311.3M | ||
| Q2 24 | — | $-321.7M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $396.9M | ||
| Q3 25 | $2.4B | $396.1M | ||
| Q2 25 | $2.4B | $342.9M | ||
| Q1 25 | — | $327.2M | ||
| Q4 24 | — | $350.9M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $395.6M |
| Q1 26 | 0.19× | — | ||
| Q4 25 | 0.22× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $74.6M |
| Free Cash FlowOCF − Capex | — | $74.6M |
| FCF MarginFCF / Revenue | — | 156.3% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $74.6M | ||
| Q3 25 | $12.4M | $47.6M | ||
| Q2 25 | $10.7M | $-15.1M | ||
| Q1 25 | — | $20.0M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | — | $33.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $74.6M | ||
| Q3 25 | $12.4M | $47.6M | ||
| Q2 25 | $10.6M | $-15.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | — | $33.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 156.3% | ||
| Q3 25 | 25783.3% | 39.0% | ||
| Q2 25 | 48.6% | -17.7% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 35.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | 72.9% | 0.0% | ||
| Q2 25 | 0.3% | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | 1.84× | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVBH
| Net Interest Income | $26.5M | 95% |
| Noninterest Income | $1.5M | 5% |
IRWD
Segment breakdown not available.
